None listed
Conditions
Interventions
Intervention1: KMBF – A (B.No: AJA-136 /20.02.2023): An amount of 4-5 drops has to be applied on the split face. Duration - 8 weeks
Control Intervention1: KMBF – KIH – 2 (B.No: KAKKLBT- 002 / 28.02.20
Sponsors
Kama Ayurveda Pvt. Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy female subjects, as determined from a recent medical history. 2. Healthy female subjects, as determined from a recent medical history. 3. Subjects in the age group of 18-55 years (both ages inclusive). 4. Subjects having dull skin with G&R index =2.5 5. Subjects having spots and undereye pigmentation as per the dermatologist’s discretion 6. Subjects who agree not to use any other make up remover/ creams/micellar water/makeup wipes during the study duration. 7. Subjects willing to give a voluntary written informed consent and agree to come for regular follow up. 8. Subjects willing to abide by and comply with the study protocol. 9. Subjects willing to give voluntary written informed consent and agree to come for regular follow-up. 10. Subjects who have not participated in a similar investigation in past four weeks. 11. Subjects who are willing not to participate in any other clinical study during participation in the current study.
Exclusion criteria
Exclusion criteria: 1. A known history or present condition of an allergic response to any cosmetic products. 2. Change personal nutrition habits as well as sports habits 3. Start or change their oral hormonal treatment or their oral contraception 4. Subject having active skin diseases (e.g., active atopic dermatitis, pigmented contact dermatitis or other cutaneous manifestations), which will interfere with the assessment. 5. Subjects on oral medications (e.g. steroids, anti-oxidant) which will compromise the study. 6. Subjects with wounds, sunburn, scars, tattoos or piercings at the skin test site(s) 7. Subjects who apply ointments, creams, etc. for antibacterial, anti-allergic, or immunosuppressive treatment of the skin at the test site(s). 8. Systemic treatment which may modify the cutaneous state on the day of inclusion or in the previous 30 days, including retinoid therapy. 9. History of intense sun exposure and/ photo toxicity/allergy. 10. Female subjects who are pregnant, lactating or nursing. 11. Chronic illness which may influence the cutaneous state. 12. Subject participating in any other cosmetic or therapeutic trial. 13. Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study has been designed to evaluate the effectiveness of test products in providing glow and radiance and skin lightening and other associative parameters by dermatological expert evaluation and standard instrumentsTimepoint: Baseline Week 2 Week 4 Week 8 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 To evaluate skin hydration in comparison to the comparator product. 2 Immediate and long-term benefits with regular use of the products for 2 weeks, 4 weeks and 8 weeks in providing skin brightening, hydration, firmness and associated skin attributes as per subject feedback using a standard questionnaire on a 5-pointer scale in comparison to the comparator product.Timepoint: Baseline Week 2 Week 4 Week 8 | — |
Countries
India
Contacts
Public ContactDr Mukesh Ramnane
MS Clinical Research Pvt Ltd
Outcome results
None listed